SUNITCAP-SUNITINIB MALATE CAPSULES 50MG

ITC-HSN: 30041090

Price on Request

Min Order Qty 1 Bottle

  • Product not available

Description
SUNITCAP 50 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing cancer progression.

Uses
Sunitinib is used in adults for the treatment of:

1. Advanced / metastatic Renal Cell Carcinoma (RCC)

2. Gastrointestinal Stromal Tumor (GIST)
    – After failure or intolerance to imatinib

3. Pancreatic Neuroendocrine Tumors (pNETs)
    – Unresectable or metastatic, well-differentiated rx_img
Prescription Required

RADHAKRUSHNA MEDICALS

Yavatmal, India

Business Operations: Merchant

Contact us for


By clicking on ‘Send Trade Enquiry’, you agree to our terms & condition and user policies

Common side effects:

•   Fatigue, weakness

•   Diarrhea

•   Nausea and vomiting

•   Decreased appetite, weight loss

•   Hypertension

•   Hand–foot syndrome

•   Mouth ulcers (stomatitis)

•   Skin and hair color changes

Serious side effects:

•   Cardiac toxicity (reduced LVEF, heart failure)

•   Severe hypertension

•   Thyroid dysfunction (hypothyroidism)

•   Bleeding or thromboembolic events

•   Liver toxicity

 Regular monitoring of blood pressure, thyroid function, liver function, and cardiac status is mandatory.

Dosage
Dosage is based on indication and patient tolerance.

Standard dosing:

•   50 mg once daily for 4 weeks ON, 2 weeks OFF
    (One treatment cycle = 6 weeks)

Alternative dosing:

•   37.5 mg once daily continuously (commonly in pNETs)

    Dose reduction may be done using 25 mg or 12.5 mg capsules if toxicity occurs.

Established in: 2021
Bussiness Type: Sole Proprietorship
Bussiness Type: Merchant
MSME: Yes
Countries exporting to: United States, Philippines, Smaller Territories of the UK, United Kingdom, Bangladesh, Pakistan, Nepal, United Arab Emirates, Australia, Malaysia, Canada, Korea North, Korea South, Thailand, Mexico, Saudi Arabia, Bulgaria, Russia, Poland, Ethiopia, Zimbabwe, Taiwan, Albania, Azerbaijan, Brazil, Tanzania, Bhutan, France, Kuwait, Egypt, Vietnam, Belgium, Belarus, Congo, Czech Republic, Germany, Greece, Greenland, Indonesia, Iran, Israel, Italy, Japan, Jordan, Kenya, Latvia, Lebanon, Liberia, Lithuania, Macedonia, Afghanistan
Export Turnover (3 years): US$10,000 to US$50,000
Countries would like to export to: Austria, United States, United Kingdom, Turkey, Thailand, Switzerland, Sri Lanka, South Africa, Bangladesh, Albania, American Samoa, Anguilla, Malaysia, Canada, Korea North, Japan, Korea South, Uzbekistan, Azerbaijan, Bhutan, Belgium, Australia, Afghanistan, Mexico, France, Ethiopia, Germany, Netherlands Antilles, Tanzania, Turks And Caicos Islands, Italy, Bulgaria, Greece, Greenland, Indonesia, Iran, Iraq, Congo, Latvia, Lebanon, Liberia, Lithuania, Kenya, Central African Republic, United Arab Emirates, Philippines, Algeria, Andorra
No of employees: 1-10

Related Products